By sequencing cancer-cell genomes, scientists have discovered vast numbers of genes that are mutated, deleted or copied in cancer cells. This treasure trove is a boon for researchers seeking new drug targets, but it is nearly impossible to test them all in a timely fashion. To help speed up the process, MIT researchers have developed RNA-delivering nanoparticles that allow for rapid screening of new drug targets in mice.
read more
In a new study, scientists have searched for mutations in the gene regions of more than 100 kidney cancer samples, the largest number of samples from a single tumour type to be sequenced to date. Clear cell renal cell carcinoma (ccR... Read Post
By sequencing cancer-cell genomes, researchers have found a substantial amount of genes that happen to be mutated, deleted or duplicated within cancerous cells. This treasure chest is a great asset for scientists searching for innov... Read Post
CAMBRIDGE, MA -- By sequencing cancer-cell genomes, scientists have discovered vast numbers of genes that are mutated, deleted or copied in cancer cells. This treasure trove is a boon for researchers seeking new drug targets, but it... Read Post